Infections in children undergoing allogeneic bone marrow transplantation in India

Biju George1, Vikram Mathews, Auro Viswabandya

  • 1Department of Haematology, Christian Medical College, Vellore, Tamil Nadu, India. biju@cmcvellore.ac.in

Pediatric Transplantation
|February 28, 2006
PubMed

Insights

This study analyzed infections in pediatric patients after allogeneic transplants, finding viral infections common post-transplant and bacterial infections earlier. Infection-related mortality was 12%, with profiles similar to Western reports.

Area of Science:

  • Pediatric Hematology-Oncology
  • Infectious Diseases
  • Transplant Medicine

Background:

  • Allogeneic transplants in pediatric patients are susceptible to various infections.
  • Febrile neutropenia is a common complication post-transplant.
  • Understanding infection profiles is crucial for patient management.

Purpose of the Study:

  • To investigate the clinical profile and outcomes of infections in pediatric patients undergoing allogeneic transplants.
  • To identify common pathogens and their timing post-transplant.
  • To compare infection patterns over different time periods and with international data.

Main Methods:

  • Retrospective analysis of 221 pediatric patients receiving 230 allogeneic transplants (1986-2004).
  • Documentation and categorization of all infections, including bacterial, viral, and fungal.
  • Subgroup analysis comparing pre-1998 and post-1998 eras.

Main Results:

  • Viral infections (45.7%) were most common, particularly >30 days post-transplant (e.g., Cytomegalovirus).
  • Bacterial infections (36.9%), mainly gram-negative, predominated within 30 days (e.g., NFGNB, Pseudomonas).
  • Fungal infections (11.1%, predominantly Aspergillus) and tuberculosis were also observed; infection-related mortality was 12%.

Conclusions:

  • The infection profile in Indian pediatric transplant recipients is comparable to Western data.
  • Viral infections are more frequent later post-transplant, while bacterial infections occur earlier.
  • Improvements in care may have reduced gram-negative infections and related mortality over time.